Pain Medicine · Pell City, AL
NPI
1750331542
Since 2006
Specialty
Pain Medicine
Code 208VP0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7067 Veterans Parkway, Suite 210
Pell City, AL, 35125
Phone (205) 405-7348
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
3,024 services
Medicare patients, 2024
221
Average age 70
Drug cost, 2024
$835K
15,604 prescriptions
Company payments, 2025
$128
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gaylyn M Horne was code J1885 (injection, ketorolac tromethamine, per 15 mg), 1,108 times for 84 patients. In total Gaylyn M Horne billed 3,024 services in 25 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 1,108 | 84 | $0.40 | $447 |
| 99214 Office E&M - Established | Office | 694 | 173 | $85.19 | $59K |
| 96372 Injection Administration | Office | 283 | 85 | $8.57 | $2,424 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 248 | 29 | $0.75 | $185 |
| 62323 Nerve Block Injection - Back | Facility | 166 | 80 | $70.86 | $12K |
| 96138 Behavioral Health Services | Office | 139 | 108 | $24.55 | $3,413 |
| 96132 Behavioral Health Services | Office | 103 | 92 | $101.63 | $10K |
| 62321 Nerve Block Injection - Back | Facility | 44 | 22 | $71.63 | $3,152 |
| 20610 Joint Injection | Office | 29 | 19 | $55.95 | $1,622 |
| 80305 Drug Tests | Office | 24 | 20 | $11.48 | $276 |
| 20553 Musculoskeletal | Office | 24 | 15 | $40.82 | $980 |
| 27096 Joint Injection | Facility | 22 | 12 | $64.83 | $1,426 |
| 64493 Nerve Block Injection - Back | Facility | 18 | 13 | $95.34 | $1,716 |
| 64494 Nerve Block Injection - Back | Facility | 18 | 13 | $54.10 | $974 |
| 99205 Office E&M - New | Office | 12 | 12 | $161.77 | $1,941 |
By year: 2022 $81K for 2,688 services; 2023 $95K for 3,014 services; 2024 $104K for 3,024 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 24 | 20 | $11.48 | $276 |
Medicare prescription drug claims, 2024
In 2024, the drug Gaylyn M Horne prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,336 prescriptions and refills. In total Gaylyn M Horne wrote 15,604 Medicare prescriptions that cost $835K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,336 | 2,338 | 274 | $59K |
| Gabapentin Generic | 2,015 | 2,132 | 297 | $22K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,935 | 1,935 | 210 | $49K |
| Tizanidine Hcl Generic | 890 | 1,057 | 164 | $14K |
| Pregabalin Generic | 693 | 709 | 108 | $16K |
| Cyclobenzaprine Hcl Generic | 515 | 545 | 111 | $4,844 |
| Tramadol Hcl Generic | 507 | 518 | 79 | $5,040 |
| Methocarbamol Generic | 490 | 512 | 119 | $7,332 |
| Diclofenac Sodium Generic | 367 | 377 | 85 | $12K |
| Buprenorphine Hcl Generic | 351 | 353 | 51 | $22K |
| Morphine Sulfate Er Morphine Sulfate | 319 | 319 | 38 | $10K |
| Trazodone Hcl Generic | 262 | 324 | 38 | $2,036 |
| Baclofen Generic | 257 | 290 | 45 | $4,730 |
| Buprenorphine Generic | 254 | 254 | 46 | $84K |
| Oxycodone Hcl Generic | 240 | 240 | 24 | $5,440 |
Brand drugs: 797 claims; generic drugs: 14,807 claims; opioid claims: 6,164.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gaylyn M Horne $128 ($128 in general payments such as food, travel and fees) from 4 companies. The largest payer was Collegium Pharmaceutical, Inc. with $43.19.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.